| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954438 | Cancer Epidemiology | 2018 | 8 Pages |
Abstract
Outcomes for adults with bone and soft-tissue cancer in Europe began to improve around 2005; new therapeutic developments are expected to result in further progress. Survival improvements already achieved must be brought more fully to elderly patients and those in Eastern Europe. European Reference Networks on rare cancers will have a vital role in future progress.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Charles A. Stiller, Laura Botta, David H. Brewster, Vincent K.Y. Ho, Anna Maria Frezza, Jeremy Whelan, Paolo G. Casali, Annalisa Trama, Gemma Gatta, the EUROCARE-5 Working Group the EUROCARE-5 Working Group,